Literature DB >> 17395800

Clinical research. Testing a novel strategy against Parkinson's disease.

Jennifer Couzin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395800     DOI: 10.1126/science.315.5820.1778

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  Expression of leucine-rich repeat kinase 2 (LRRK2) inhibits the processing of uMtCK to induce cell death in a cell culture model system.

Authors:  Jie Cui; Mei Yu; Jingwen Niu; Zhenyu Yue; Zhiheng Xu
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

Review 2.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

3.  Regulation of respiration in brain mitochondria and synaptosomes: restrictions of ADP diffusion in situ, roles of tubulin, and mitochondrial creatine kinase.

Authors:  Claire Monge; Nathalie Beraud; Andrey V Kuznetsov; Tatiana Rostovtseva; Dan Sackett; Uwe Schlattner; Marko Vendelin; Valdur A Saks
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

Review 4.  Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.

Authors:  Huajun Jin; Arthi Kanthasamy; Anamitra Ghosh; Vellareddy Anantharam; Balaraman Kalyanaraman; Anumantha G Kanthasamy
Journal:  Biochim Biophys Acta       Date:  2013-09-20

Review 5.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

Authors:  Sudhakar Raja Subramaniam; Marie-Francoise Chesselet
Journal:  Prog Neurobiol       Date:  2013-04-30       Impact factor: 11.685

6.  Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.

Authors:  Ross B Mounsey; Peter Teismann
Journal:  Parkinsons Dis       Date:  2010-12-26

7.  Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying.

Authors:  Richard Kones
Journal:  Clin Pharmacol       Date:  2010-09-17

Review 8.  Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View.

Authors:  Roberta Filograna; Mariano Beltramini; Luigi Bubacco; Marco Bisaglia
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.